After 21 Years and a Spinoff, Profitability Finally Arrives
Ironwood Pharmaceuticals is in the black for the first time thanks to its complex spinoff of pre-commercial drug development programs.
M&A Market Guts Shareholder Value in Second Quarter
Shares of deal-making companies worldwide underperform MSCI stock indices for a record seventh consecutive quarter.
Sales Calls from Inside Prison Walls
Lead-generation firm Televerde puts purpose over profit by employing hundreds of incarcerated women to make sales calls and improve their lives.
M&A Didn’t Add Value in 2018. How About 2019?
While acquiring companies have underperformed stock indexes for the past two years, the outlook for M&A may be brightening.
Acquisitions Boost Short-Term Stock Value
While there are different ways to measure the success of M&A deals, shortly after deals close investors tend to expect they'll deliver incremental value.
Are Buyers Fudging the Synergies of M&A Deals?
Although acquisitions frequently fail, acquiring companies are ballyhooing their financial benefits as transaction prices steadily rise.
Usage of Variance Analysis Is, Well, Variable
While it's not debatable that variance analysis is an important FP&A tool, companies differ in how they apply it.
Share Buybacks: Who Really Benefits?
Corporations should exist for a greater purpose than maximizing value to shareholders — and executives.
What Kind of Value Generator is Your Company?
Is your company a golden goose, a unicorn, or a ship of the desert?
‘Shareholder Value’ for Private Companies
Private companies may benefit even more from a shareholder value focus than publicly listed companies do.
Softbank to Split Domestic, Overseas Units
The Japanese conglomerate's move may ease investor concerns that it would use money earned in Japan to help turn around loss-making Sprint.